Evans Center for Interdisciplinary Biomedical Research (Evans Center)
The goal of the Evans Center is to promote growth and discovery in emerging interdisciplinary biomedical research and educational areas by providing faculty affiliated with the Department of Medicine and with various schools, departments and centers at Boston University a dynamic, interdisciplinary organizational structure, which allows investigators with different areas of expertise to collectively address mechanisms of disease, and to facilitate new training opportunities.
Faculty affiliated with the Evans Center hold academic appointments with different departments. The Center provides opportunities for collaborations within Affinity Research Collaboratives (ARCs) organized around foci of common research interests. The extraordinary strength in biomedical and physical sciences at Boston University, and the support and development of the ARCs create opportunities for new interdisciplinary approaches to both research and training in biomedical research. Basic science discovery promoted by ARCs are also available to the Clinical and Translational Science Institute and to other centers for collaborative translational applications.
SAVE THE DATES
LAST CHANCE TO REGISTER for BOSTON UNIVERSITY’s 3rd ANNUAL
CANCER CARE FOR ENGINEERS AND SCIENTISTS CONFERENCE
May 13-14, 2013
Register Now <http://nano-cancer.bu.edu/events/show/1012>
Principal sponsor: The Center for Nanoscience and Nanobiotechnology.
Co-sponsors: The Evans Center for Interdisciplinary Biomedical Research, NIBIB Center for Future Technologies in Cancer Care (CFTCC), The Office of the Dean of the School of Medicine, and The Office of the Vice President and Associate Provost for Research.
Objective: To educate scientists and engineers about key concepts in clinical cancer care, including current controversies and areas of need. The goal of the conference is to provide a basis of knowledge to inspire physical and engineering scientists to work together with cancer researchers and clinicians to advance our understanding of cancer and to develop diagnostic, therapeutic and imaging tools. No background in cancer biology is assumed. This conference is appropriate for faculty members, graduate students, and postdoctoral scholars in physics, chemistry, biomedical and engineering.
As always, attendance is FREE, but registration is required. Registration includes a continental breakfast and lunch both days of the workshop and the poster session reception on the evening of May 13. Please register on-line <http://nano-cancer.bu.edu/forms/show/short-course-registration-2013> .
A full schedule and registration information is available at http://nano-cancer.bu.edu/ <http://nano-cancer.bu.edu/>
Jennifer E. Rosen, M.D. F.A.C.S.
Assistant Professor of Surgery and Molecular Medicine and Attending Surgical Oncologist at Boston University School of Medicine
Bennett Goldberg, Ph.D.
Professor of Physics, Biomedical Engineering, and Electrical and Computer Engineering and Director of the Center for Nanoscience and Nanobiotechnology at Boston University
Monday, June 17, 2013
650 Albany Street, X714/715
1:30 – 4:30 pm
The Evans Center for Interdisciplinary Biomedical Research Presents the 2013 Evans Center Fellows
1:30 – 2:00 Coffee/Refreshments, Networking and Welcome
2:00 – 2:20 Dr. Tamar Aprahamian, Assistant Professor
Sex Differences in Adipose Tissue Biology and Related Metabolic Disease ARC
“Functional consequences of angiogenesis in adipose tissues”
2:30 – 2:50 Dr. Marc Liesa, Postdoctoral Associate
Mitochondria in Health and Disease ARC
“A novel antioxidant system constituted by the mitochondrial ATP binding cassette transporter ABCB10”
3:00 – 3:20 Dr. GyungahJun, Assistant Professor
Protein Trafficking & Neurodegenerative Disease ARC
“Interdisciplinary Research of Translational Medicine for Alzheimer’s Disease”
3:30 – 3:50 Dr. Cesar Sommer, Postdoctoral Associate
BU iPS Bank ARC
“Modeling Familial Adenomatous Polyposis using Induced Pluripotent Stem Cells “
Followed by a wine & cheese reception at 4pm
Please RSVP to: Robin MacDonald (email@example.com)
2013 ARC Directors Luncheon Meetings
Wednesday February 13, 12:00-1:15, W-502
Monday June 17, 12:00-1:15, W-502
Monday September 9, 12:00-1:15, W-502
Current ARC Meetings (announcements of special seminars/presentations may be found on the ARC pages)
Calcium Homeostasis in Health and Disease, Special Seminars will be announced; Focus Group Meetings will be on the First and Last Thursdays of each month, adjusting for holidays (1/3, 1/24, 2/7, 2/28, 3/7, 3/28, 4/4, 4/25, 5/2, 5/30, 6/6, 6/27, 7/11, 7/25, 8/1, 8/29, 9/5, 9/26, 10/3, 10/31, 11/7, 11/21, 12/5, 12/19), 2:30-4pm, CABR 502 at 700 Albany Street, Medical Campus
Protein Trafficking and Neurodegenerative Diseases, 2nd Monday of each month, 9:30-10:30am, Biomedical Genetics Conference Room, L311 at 88 East Newton Street, Medical Campus
BU iPS Cell Bank/Regenerative Medicine, 1st Tuesday of each month, 9-10am, R3
Mitochondria in Health and Disease (mtARC), Wednesdays at 4pm; specific dates will be announced as speakers are scheduled, EBRC 714 at 650 Albany Street, Medical Campus
Molecular, Biomechanical and Genetic Mechanisms of Arterial Stiffness, Tuesdays at 4pm; please watch for details, location is shared between 44 Cummington St, ERB 203, Charles River Campus and EBRC 714 at 650 Albany Street, Medical Campus
Sex Differences in Adipose Tissue Biology and Related Metabolic Diseases, Wednesdays at 4 pm; please watch for specific dates and other meetings as available, locations will be announced
Nanotheranostic Platforms for Cancer and Vascular Disease, Meetings will be announced; location is shared between Photonics Building at 8 St. Mary’s Street, Charles River Campus and EBRC at 650 Albany Street, Medical Campus
Metabolic Disease and Insulin Resistance: Studies in Patients Undergoing Bariatric Surgery, First Meeting Wednesday, Jan 30, 3:30-5:00p, CABR 502 at 700 Albany Street, Medical Campus; future meetings will be announced
Computational Genomic Models of Environment & Chemical Carcinogenicity, Meetings and location will be announced